Executive summary Rapid demographic, sociocultural, and economic transitions are driving
increases in the risk and prevalence of diabetes and other non-communicable diseases …

Background There has been a widely documented and recognized increase in diabetes
prevalence, not only in high-income countries (HICs) but also in low-and middle-income …

Aims Diabetes and its complications have a significant economic impact on individuals and
their families, health systems and national economies. Methods The direct health …

Background Differences in methods and data used in past studies have limited comparisons
of the cost of illness of diabetes across countries. We estimate the full global economic …

AIMS: To estimate the global health expenditure on diabetes among people aged 20–79
years for the years 2010 and 2030. METHODS: Country-by-country expenditures for 193 …

Background The chronic nature of noncommunicable diseases (NCD) and costs associated
with long-term care can result in catastrophic health expenditure for the patient and their …

Aims To estimate the prevalence and trends of diabetes mellitus (DM) and impaired fasting
glucose (IFG), 2005–2011, and to determine the contribution of obesity to DM prevalence …

Background Due to high prevalence of diabetes and its complications, evaluating of the
patients' quality of life is critical. EQ-5D-5 L is a valid tool for assessing the quality of life in …

Background Diabetes is one of the world's most prevalent and serious non-communicable
diseases (NCDs). It is a leading cause of death, disability and financial loss; moreover, it is …

Abstract Evaluation of health-related quality of life (HRQoL) among people with diabetes has
been growing in Iran over the last decade. The main aim of the current study was to …